The haplotype M2 within the ANXA5 gene is independently associated with the occurrence of deep venous thrombosis

• References

• 1 Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost 2009; 102: 360-370.
• 2 Pomp ER, Doggen CJ, Vos HL. et al. Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thromb Haemost 2009; 101: 62-67.
• 3 Kniffin WD, Baron JA, Barret J. et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-866.
• 4 Lane DA, Mannucci PM, Bauer KA. et al. Inherited thrombophilia. Part 1. Thromb Haemost 1996; 76: 651-662.
• 5 Kaetzel MA, Hazarika P, Dedman JR. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins. J Biol Chem 1989; 264: 14463-14470.
• 6 Bogdanova N, Horst J, Chlystun M. et al. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet 2007; 16: 573-578.
• 7 Tiscia G, Colaizzo D, Chinni E. et al. Haplotype M2 in the annexin A5 (ANXA5) gene and the occur-rence of obstetric complications. Thromb Haemost 2009; 102: 309-313.
• 8 Bertina RM, Koeleman BP, Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
• 9 Poort SR, Rosendaal FR, Reitsma PH. et al. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.